"covid-19" production of MAB product countermeasures against covid-19. Authority 10 USC 2373.
Ended Other Transaction Agreement Awarded Last action
- Contract number
- W911QY2090015
- Awardee
-
Just-Evotec Biologics Inc. UEI F9B8B9LV5NL6
- Awarding agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Obligated
- $18,407,521
Award facts
- Contract value 103% obligated
- $17,941,951.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Other
- Place of performance
- Seattle, WA 98109, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$161,542 | |
| Supplemental Agreement for work within scope | $327,063 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $18,242,000 |
About this award
Just-Evotec Biologics, Inc., doing business as Just-Evotec Biologics, has been awarded a $17.9 million other transaction agreement by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to support the production of monoclonal antibody (mAb) countermeasures against COVID-19. The contract will run from July 2020 through February 2022 and will be performed in Seattle, Washington. Under the agreement, Just-Evotec Biologics will leverage its expertise in biologics development and manufacturing to deliver mAb products for combating the COVID-19 pandemic, as authorized under 10 U.S. Code 2373. No major subcontractors or set-aside designations were indicated. The award provides key resources to the Department of Defense's chemical and biological defense programs for responding to the public health emergency.
Quick answers
Who was awarded contract W911QY2090015?
W911QY2090015 was awarded to Just-Evotec Biologics Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on July 7, 2020.
How much is contract W911QY2090015 worth?
The government has obligated $18,407,521 on W911QY2090015. Its current value, with exercised options, is $17,941,951.
Which agency awarded contract W911QY2090015?
ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911QY2090015, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W911QY2090015 competed?
The extent of competition for W911QY2090015 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award